![](/img/cover-not-exists.png)
Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer
Lv, Yaping, Cang, Wei, Li, Quanfu, Liao, Xiaodong, Zhan, Mengna, Deng, Huayun, Li, Shengze, Jin, Wei, Pang, Zhi, Qiu, Xingdi, Zhao, Kewen, Chen, Guoqiang, Qiu, Lihua, Huang, LeiVolume:
8
Journal:
Oncogenesis
DOI:
10.1038/s41389-019-0179-2
Date:
December, 2019
File:
PDF, 2.04 MB
2019